Pain Control in Children and Adolescent After Thoracic Surgery: The Effect of Gabapentin

• Status: Completed
• Trial end date: 2020-12-03
• Target enrollment: 0
• Participant gender: All

Summary

The study is performed in patients aged 5-18 years after thoracic surgery. The primary aim of this trial is to determine whether the use of gabapentin as a component of multimodal analgesic regiments reduces pain scores following thoracic surgery in pediatric patients. The secondary objective of the trial are to evaluate whether the use of gabapentin reduces postoperative anxiety scores and consumption of ropivacaine with fentanyl, decreases side-effects, and improves patient satisfaction.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute for Tuberculosis and Lung Diseases, Poland
• Treatments: Gabapentin

Criteria

Inclusion Criteria:

• 5 - 18 years of age;

• surgery: lateral thoracotomy or Ravitch procedure;

• ASA 1-3;

• postoperative analgesia: thoracic epidural analgesia or intravenous infusion of morphine.

Exclusion Criteria:

• allergy or sensitivity to gabapentin;

• history of chronic pain or daily analgesic use;

• diagnosed with psychiatric disorders;

• treated oncologically;

• with impaired verbal communication;

• the lack of postoperative chest drainage.